Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Michael Robert A., holds the title of CHIEF EXECUTIVE OFFICER at AbbVie Inc..
On 2025-02-28, the insider transacted 27,186 shares.The shares were transacted at a weighted average price of $205.02 per share, resulting in a total market-relevant value of $5.6M.
Michael Robert A. (CHIEF EXECUTIVE OFFICER) had withheld for taxes $5.6M of $ABBV
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.